B
Evidence Grade B
Graded
accuracy verified by the review judge
Safe to Cite
Current
4%
4% -- share of rd investment for biopharmaceutical industry (2026)
Only 4% of biopharmaceutical industry R&D investments go towards women-specific health needs.
Attribution:
View source
Lighthouse Research Team
Last verified:
·
How we verify data →
Source verified
Evidence graded
Value
4%
Unit
Percentage
Data Vintage
2026
Entity
Evidence Quality
B
Strong, reliable evidence
Sourced from a well-regarded research firm or industry leader with transparent methodology and a reasonably large sample.
Single source - not yet corroborated
Score breakdown
Extraction
75
Source Trust
60
Citation Chain
20
Independence
30
Methodology
45
Freshness
95
Source
Alcimed
Primary
Tier B
https://www.alcimed.com/en/expertise/women-health/ ↗
Source Article
Women’s Health: Develop research, innovation, and access
Original Research
Alcimed
· Original study ↗
Methodology
Consulting firm publication citing aggregate industry R&D allocation; original study not named
Methodology documented
Segmentation
Industrymarketing
Cite this stat
Plain Text
biopharmaceutical industry: 4% share of rd investment. Source: Alcimed (2026). Via Lighthouse Intelligence -- https://lighthousedata.io/data/biopharma-rd-investment-womens-health-4pct
HTML Embed
<blockquote cite="https://lighthousedata.io/data/biopharma-rd-investment-womens-health-4pct" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>4%</strong> -- share of rd investment for biopharmaceutical industry<br><small>Source: Alcimed (2026) · <a href="https://lighthousedata.io/data/biopharma-rd-investment-womens-health-4pct" target="_blank" rel="noopener">Lighthouse Intelligence</a></small></blockquote>
Share
Use this data in your work
Copy the citation, embed the widget, or explore thousands more verified marketing statistics -- all free.